Latest News - West Pharmaceutical
Top Corporates Hub
West Pharmaceutical
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
09.10.2026 13:58
AngioDynamics beats first-quarter earnings estimates as revenues rise 6.9% on strong Med Tech growth, with margin expansion and robust Auryon and NanoKnife sales.
West to Host Third-Quarter 2026 Conference Call
08.10.2026 10:00
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results before the market opens on Thursday, October 29, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.
West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price
08.10.2026 03:35
West Pharmaceutical's sustained premium valuation demands proven earnings and cash flow improvements. See why I rate WST stock a Sell.
West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short
08.10.2026 00:16
West Pharmaceutical Services has seen its share price climb sharply in recent periods, and that kind of run naturally raises a question for anyone looking at the stock today: Are the cash flows the business can generate over time enough to support where the market is currently pricing West Pharmaceutical Services? The share price has gained 37.2% over the past year, which puts a lot of weight on whether the underlying cash flows can keep backing up that move. The group’s role in supplying...
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
06.10.2026 14:17
MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
06.10.2026 14:15
GEHC's $945M SOFIE Biosciences deal will expand its U.S. PET radiopharmaceutical footprint and boost exposure to precision care growth.
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
06.10.2026 13:44
CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
29.09.2026 14:04
ITGR's $127-a-share KKR deal offers defined cash value, while core franchises face slow new-product adoption.
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
24.09.2026 15:46
Glaukos' iDose and Epioxa are driving growth, while recurring treatments, high margins and a broad pipeline support its long-term prospects.
1 Surging Stock with Solid Fundamentals and 2 That Underwhelm
21.09.2026 07:34
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
16.09.2026 15:38
AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
16.09.2026 15:37
Intuitive Surgical's CE mark expands da Vinci SP into transvaginal gynecology in Europe, opening a new women's health opportunity and growth runway.
BLCO Gains European CE Mark for Next-Gen SeeLyra Femtosecond Laser
14.09.2026 15:14
Bausch + Lomb gains European CE Mark approval for SeeLyra, expanding its surgical portfolio with a compact laser platform for cataract and corneal procedures.
West Pharmaceutical Services, Inc. (WST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
14.09.2026 11:21
West Pharmaceutical Services, Inc. (WST) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsRobert...
Novocure Reports Patient Data Exposure in Cybersecurity Incident
07.09.2026 16:12
NVCR says a cyber incident exposed limited patient and contact data, but devices stayed secure and operations remained fully functional.
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?
07.09.2026 14:42
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” second quarter 2026 investor letter. The letter can be downloaded here. The letter discusses the challenges of AI-driven market concentration and emphasizes the potential for long-term investors. It notes that the best companies are currently underperforming due to market returns being concentrated in […]
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap
05.09.2026 02:13
How West Pharmaceutical Services stock has been performing West Pharmaceutical Services (WST) has drawn investor attention after recent share price moves, with the stock closing at US$339.97 on 3 September 2026. The company shows mixed returns over different periods, including gains over the past year alongside shorter term pullbacks. For West Pharmaceutical Services, the recent 1-day share price decline of 0.81% and 3.15% share price pullback over 30 days sit against a much stronger...
1 Mid-Cap Stock on Our Buy List and 2 Facing Headwinds
01.09.2026 16:54
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
01.09.2026 15:10
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
06.08.2026 16:31
LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.